ARK Invest Rotates Capital From Medical Hardware Into Genomic Data and Cloud Infrastructure

ARK Invest's portfolio risk exposure is now more sensitive to cloud buildouts, power availability, and the economics of scaling data centers. This shift follows a rotation toward data center capacity, precision medicine, and next-generation energy. On April 9, Cathie Wood sold 57,700 shares of Strata Critical Medical and 3,478 shares of BWX Technologies. The divestment from Strata Critical Medical follows a pattern of selling medical device companies that lack software and algorithm functionality. ARK Invest also reduced holdings in select semiconductor and internet names to fund purchases of 32,800 shares of GeneDx Holdings, a company that stores genomic data of rare diseases and pediatric illnesses, and 3,447 shares of Arcturus Therapeutics. The firm also bought $11 million of a megacap tech stock as part of a repositioning around compute, networking, and cloud capacity.